Southeastern Ohio Regional Medical Center INC

Southeastern Ohio Regional Medical Center INC was paid $19.26M by Medicaid between Jan 2018 and Dec 2024, across 295 billing codes. Its largest line is 99283, emergency room visit (moderate) — 14% of everything it billed.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	58,779	$1.47M
2019	57,300	$1.34M
2020	50,990	$1.55M
2021	61,313	$1.94M
2022	73,699	$2.44M
2023	201,232	$6.49M
2024incomplete	93,197	$4.03M

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
99283	Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity	14%	25,261	22,925	$2.77M
99284	Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity	12%	20,839	18,223	$2.40M
96361	Intravenous infusion, hydration; each additional hour	9.3%	6,972	5,080	$1.80M
99282	Emergency department visit for the evaluation and management, low to moderate severity	4.8%	9,642	8,837	$927K
99285	Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life	4.4%	7,354	6,316	$857K
97110	Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion	4.3%	12,052	2,822	$838K
0241U	Neonatal screening for hereditary disorders, genomic sequence analysis panel	4.1%	5,452	4,588	$785K
74177	Computed tomography, abdomen and pelvis; with contrast material	3.7%	2,934	2,452	$708K
70450	Computed tomography, head or brain; without contrast material	3.5%	3,288	2,865	$675K
92507	Treatment of speech, language, voice, communication, and/or auditory processing disorder	2.4%	6,688	2,061	$465K
96365	Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour	2.1%	2,613	1,821	$395K
80053	Comprehensive metabolic panel	1.9%	34,958	29,822	$375K

283 more codes

59025	Fetal non-stress test	1.9%	2,480	$374K
74176	Computed tomography, abdomen and pelvis; without contrast material	1.7%	1,365	$331K
97530	Therapeutic activities, direct patient contact, each 15 minutes	1.6%	4,321	$316K
87491	Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe	1.6%	6,651	$305K
99213	Doctor's office visit, returning patient (routine)	1.1%	4,487	$217K
71275	Computed tomographic angiography, chest, with contrast material	1.1%	794	$210K
11042	Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm	1.1%	1,809	$206K
96366	Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour	<1%	758	$182K
87591	Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe	<1%	6,644	$180K
99212	Office or other outpatient visit for the evaluation and management of an established patient, straightforward	<1%	2,071	$163K
96360	Intravenous infusion, hydration; initial, 31 minutes to 1 hour	<1%	799	$160K
84443	Thyroid stimulating hormone (TSH)	<1%	8,216	$153K
94640	Pressurized or nonpressurized inhalation treatment for acute airway obstruction	<1%	1,382	$138K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	43,874	$136K
G0378	Hospital observation service, per hour	<1%	1,680	$125K
80061	Lipid panel	<1%	7,391	$106K
87086	Culture, bacterial; quantitative colony count, urine	<1%	13,228	$106K
U0004	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r	<1%	742	$103K
87661	Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe	<1%	3,531	$98K
71046	Radiologic examination, chest; 2 views	<1%	5,343	$96K
88175	Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer	<1%	5,311	$93K
87637	Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV	<1%	2,146	$93K
93306	Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete	<1%	372	$88K
96413	Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance	<1%	930	$80K
99214	Doctor's office visit, returning patient (more involved)	<1%	1,138	$74K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	2,794	$73K
J3490	Unclassified drugs	<1%	12,849	$72K
82607		<1%	2,529	$67K
80048	Basic metabolic panel (calcium, ionized)	<1%	5,128	$59K
97140	Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage)	<1%	1,859	$55K
76705	Ultrasound, abdominal, real time with image documentation; limited	<1%	562	$53K
43239	Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple	<1%	131	$50K
87624	Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types	<1%	1,240	$48K
80307	Drug test(s), presumptive, any number of drug classes; immunoassay	<1%	4,370	$48K
97016		<1%	1,351	$47K
92526		<1%	1,642	$46K
95810	Polysomnography; sleep staging with 4 or more additional parameters	<1%	87	$46K
74018		<1%	894	$43K
84439		<1%	2,142	$42K
87070		<1%	1,790	$41K
77063	Screening digital breast tomosynthesis, bilateral	<1%	892	$41K
71260	Computed tomography, thorax, diagnostic; with contrast material	<1%	158	$36K
97533		<1%	671	$33K
73630		<1%	983	$31K
96367		<1%	539	$29K
87400		<1%	3,185	$29K
83036	Hemoglobin; glycosylated (A1C)	<1%	2,185	$28K
36415	Collection of venous blood by venipuncture	<1%	37,017	$27K
80081		<1%	844	$26K
97161		<1%	774	$25K
93005	Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report	<1%	14,326	$24K
73610		<1%	758	$24K
85027		<1%	2,077	$24K
76642		<1%	199	$23K
92557		<1%	388	$22K
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	<1%	150	$22K
92587		<1%	443	$22K
84702		<1%	1,137	$21K
86592		<1%	600	$20K
87801	Infectious agent detection by nucleic acid; amplified probe, multiple organisms	<1%	894	$20K
G0481	Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed	<1%	691	$20K
84484		<1%	9,590	$20K
73130		<1%	643	$20K
72100		<1%	338	$19K
45380	Colonoscopy, flexible; with biopsy, single or multiple	<1%	67	$17K
73030		<1%	487	$16K
82728		<1%	1,262	$16K
73560		<1%	383	$16K
G0463	Hospital outpatient clinic visit for assessment and management of a patient	<1%	4,025	$16K
87081		<1%	2,271	$16K
97035		<1%	311	$15K
87510		<1%	565	$15K
93971		<1%	179	$14K
82172		<1%	636	$14K
94060		<1%	140	$14K
76856	Ultrasound, pelvic (nonobstetric), real time with image documentation; complete	<1%	72	$14K
99281	Emergency department visit for the evaluation and management, self-limited or minor	<1%	119	$13K
88305	Level IV - Surgical pathology, gross and microscopic examination	<1%	1,149	$13K
86850		<1%	564	$13K
87798	Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism	<1%	891	$13K
87077		<1%	1,332	$12K
97014		<1%	343	$12K
12001		<1%	94	$12K
71250		<1%	227	$12K
84481		<1%	772	$12K
73110		<1%	369	$12K
80076		<1%	794	$11K
80320		<1%	1,376	$11K
82553		<1%	1,882	$10K
71045	Radiologic examination, chest; single view	<1%	6,580	$10K
77067	Screening mammography, bilateral, including computer-aided detection	<1%	895	$10K
82950		<1%	697	$10K
U0002	2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc	<1%	1,274	$9K
86140		<1%	1,063	$9K
76830	Ultrasound, transvaginal	<1%	142	$8K
83540		<1%	1,202	$8K
72131		<1%	210	$8K
86900		<1%	678	$8K
87480		<1%	565	$8K
36591		<1%	1,637	$8K
87660		<1%	566	$8K
86803		<1%	339	$8K
72125	Computed tomography, cervical spine; without contrast material	<1%	721	$7K
84466		<1%	1,164	$7K
82677		<1%	200	$7K
97112	Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination	<1%	141	$7K
84146		<1%	317	$7K
94726		<1%	140	$7K
94729		<1%	139	$7K
82805		<1%	245	$6K
83735		<1%	4,989	$6K
84153		<1%	364	$6K
43235		<1%	21	$6K
87186		<1%	1,224	$6K
82378		<1%	1,055	$6K
95811		<1%	13	$6K
97162		<1%	238	$6K
76775		<1%	63	$6K
73562		<1%	109	$5K
74174		<1%	70	$5K
82105		<1%	219	$5K
76536		<1%	39	$5K
87389	Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies	<1%	306	$5K
73502		<1%	153	$5K
96372	Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular	<1%	4,474	$5K
M0243	Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring	<1%	13	$5K
97597		<1%	133	$4K
85610		<1%	7,468	$4K
82746		<1%	334	$4K
J0131	Injection, acetaminophen, not otherwise specified,10 mg	<1%	820	$4K
72110		<1%	145	$4K
72040		<1%	61	$4K
83695		<1%	356	$4K
86038		<1%	128	$4K
82947		<1%	2,368	$3K
92567		<1%	511	$3K
87522	Neg quan hep c or qual rna	<1%	72	$3K
83880		<1%	1,999	$3K
86901		<1%	678	$3K
82977		<1%	297	$3K
85652		<1%	902	$3K
72148	Magnetic resonance imaging, lumbar spine; without contrast material	<1%	25	$3K
81001		<1%	11,976	$3K
78452	Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress	<1%	13	$3K
86336		<1%	202	$3K
83605		<1%	4,975	$3K
12002		<1%	19	$3K
96375	Therapeutic injection; each additional sequential IV push	<1%	8,243	$3K
96376		<1%	1,308	$3K
84403		<1%	146	$3K
99215	Doctor's office visit, returning patient (complex)	<1%	41	$3K
73090		<1%	146	$3K
87340		<1%	97	$2K
96374	Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance	<1%	12,180	$2K
82570		<1%	261	$2K
83001		<1%	94	$2K
84436		<1%	416	$2K
87040		<1%	2,003	$2K
99211	Office or other outpatient visit for the evaluation and management of an established patient, minimal severity	<1%	35	$2K
81025		<1%	6,724	$2K
87807		<1%	225	$2K
93017		<1%	30	$2K
83690		<1%	6,695	$2K
99204	Doctor's office visit, new patient (more involved)	<1%	13	$2K
82565		<1%	212	$2K
86618		<1%	120	$1K
73590		<1%	108	$1K
87205		<1%	403	$1K
87147		<1%	176	$1K
72072		<1%	28	$1K
80069		<1%	85	$1K
82043		<1%	156	$1K
85018		<1%	202	$1K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	<1%	380	$1K
97165		<1%	39	$1K
82550		<1%	5,036	$986.12
90715		<1%	53	$957.82
97116		<1%	30	$947.13
87880	Infectious agent antigen detection by immunoassay; Streptococcus, group A	<1%	1,806	$919.54
81003		<1%	4,941	$863.13
J1642	Injection, heparin sodium, (heparin lock flush), per 10 units	<1%	3,010	$809.82
86677		<1%	40	$804.43
82784		<1%	46	$716.03
A4452	Tape, waterproof, per 18 square inches	<1%	261	$698.46
86780		<1%	26	$685.20
86431		<1%	37	$684.99
99205	Prolong outpt/office vis	<1%	12	$662.49
82248		<1%	87	$661.76
84100		<1%	625	$628.37
85379		<1%	1,583	$595.38
71101		<1%	30	$573.39
83655		<1%	18	$532.59
87045		<1%	43	$523.97
84479		<1%	339	$519.15
84145		<1%	595	$481.37
80074		<1%	33	$478.82
82670		<1%	14	$469.34
77065	Tomosynthesis, mammo	<1%	26	$468.42
Q9967	Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml	<1%	5,290	$465.65
87493		<1%	32	$427.52
85730		<1%	6,226	$421.31
70486		<1%	44	$415.47
84460		<1%	98	$399.03
73140		<1%	19	$398.25
84402		<1%	15	$387.22
77062		<1%	14	$373.99
82247		<1%	54	$369.43
J2270	Injection, morphine sulfate, up to 10 mg	<1%	1,648	$365.22
A6257	Transparent film, sterile, 16 sq. in. or less, each dressing	<1%	10,665	$357.79
82150		<1%	674	$357.27
88141		<1%	14	$356.30
73552		<1%	46	$348.47
73080		<1%	12	$347.49
J3420	Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg	<1%	742	$341.96
00731		<1%	58	$334.64
00811		<1%	13	$334.64
82140		<1%	151	$304.17
86318		<1%	12	$303.70
74019		<1%	37	$303.57
88304		<1%	33	$291.96
J1885	Injection, ketorolac tromethamine, per 15 mg	<1%	4,906	$287.66
77066	Tomosynthesis, mammo	<1%	68	$283.38
86787		<1%	16	$277.19
84450		<1%	70	$247.87
J3475	Injection, magnesium sulfate, per 500 mg	<1%	288	$233.03
86308		<1%	23	$230.85
87651	Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe	<1%	1,758	$225.99
72128		<1%	35	$175.58
85014		<1%	40	$173.78
A4649	Surgical supply; miscellaneous	<1%	979	$148.17
88342		<1%	50	$147.80
J2405	Injection, ondansetron hydrochloride, per 1 mg	<1%	8,099	$109.57
J1100	Injection, dexamethasone sodium phosphate, 1 mg	<1%	2,417	$105.28
87427		<1%	16	$98.96
C9113	Injection, pantoprazole sodium, per vial	<1%	180	$97.81
29125		<1%	12	$92.42
J1170	Injection, hydromorphone, up to 4 mg	<1%	434	$82.69
J2930	Injection, methylprednisolone sodium succinate, up to 125 mg	<1%	512	$78.40
J0690	Injection, cefazolin sodium, 500 mg	<1%	926	$73.31
84550		<1%	13	$66.74
J7120	Ringers lactate infusion, up to 1000 cc	<1%	569	$65.91
86300		<1%	17	$64.10
A6197	Alginate or other fiber gelling dressing, wound cover, sterile, pad size more than 16 sq. in. but less than or equal to 48 sq. in., each dressing	<1%	12	$60.76
A6454	Self-adherent bandage, elastic, non-knitted/non-woven, width greater than or equal to three inches and less than five inches, per yard	<1%	324	$60.05
80143		<1%	715	$52.38
84703		<1%	43	$52.04
36600		<1%	224	$48.56
83615		<1%	13	$43.17
J0696	Injection, ceftriaxone sodium, per 250 mg	<1%	564	$39.22
J1650	Injection, enoxaparin sodium, 10 mg	<1%	141	$37.74
J3010	Injection, fentanyl citrate, 0.1 mg	<1%	2,424	$36.61
J0780	Injection, prochlorperazine, up to 10 mg	<1%	150	$35.06
J2704	Injection, propofol, 10 mg	<1%	2,403	$33.77
A6449	Light compression bandage, elastic, knitted/woven, width greater than or equal to three inches and less than five inches, per yard	<1%	569	$33.73
J1200	Injection, diphenhydramine hcl, up to 50 mg	<1%	682	$31.63
80179		<1%	702	$26.18
J2765	Injection, metoclopramide hcl, up to 10 mg	<1%	488	$18.31
J7050	Infusion, normal saline solution, 250 cc	<1%	737	$11.93
J2250	Injection, midazolam hydrochloride, per 1 mg	<1%	5,043	$7.28
J2175	Injection, meperidine hydrochloride, per 100 mg	<1%	139	$4.07
0353U		<1%	40	$2.28
J7620	Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme	<1%	273	$1.33
J3480	Injection, potassium chloride, per 2 meq	<1%	59	$1.24
A4602	Replacement battery for external infusion pump owned by patient, lithium, 1.5 volt, each	<1%	163	$0.62
J2919	Injection, methylprednisolone sodium succinate, 5 mg	<1%	43	$0.31
J2001	Injection, lidocaine hcl for intravenous infusion, 10 mg	<1%	207	$0.06
A9575	Injection, gadoterate meglumine, 0.1 ml	0%	14	$0.00
A4550	Surgical trays	0%	213	$0.00
99152		0%	12	$0.00
82010		0%	33	$0.00
76942		0%	42	$0.00
82800		0%	100	$0.00
A9270	Non-covered item or service	0%	2,041	$0.00
A6452	High compression bandage, elastic, knitted/woven, load resistance greater than or equal to 1.35 foot pounds at 50% maximum stretch, width greater than or equal to three inches and less than five inches, per yard	0%	21	$0.00
C1727	Catheter, balloon tissue dissector, non-vascular (insertable)	0%	154	$0.00
A9500	Technetium tc-99m sestamibi, diagnostic, per study dose	0%	26	$0.00
A4616	Tubing (oxygen), per foot	0%	190	$0.00
J2060	Injection, lorazepam, 2 mg	0%	114	$0.00
87426	Infectious agent antigen detection, SARS-CoV-2 (COVID-19)	0%	62	$0.00
00813		0%	86	$0.00
J2795	Injection, ropivacaine hydrochloride, 1 mg	0%	125	$0.00
J2360	Injection, orphenadrine citrate, up to 60 mg	0%	99	$0.00
99153	Mod sedat endo service >5yrs	0%	15	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialELLIOTT, WENDY (CEO)